Optimal Asthma Control
2024 · Higher is better
Doctor · Pulmonary disease · Silt, CO
2024 · Higher is better
2024 · Higher is better
Met the knee-function target 9 to 15 months after surgery. CMS rates this 1 of 5 stars.
CMS files are dated Sep 10, 2026 to Oct 15, 2026·Model ml-4·Coverage and freshness
Loading…
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better. It does not predict your own result.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultsNoRiskExac.
Patient not at elevated risk of exacerbation for patients 18 to 50 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultCtrlNoExacRisk.
Percentage of adult patients (aged 18-50 years) with well-controlled asthma, without elevated risk of exacerbation; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Functional status after primary total knee replacement · Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
0% of this surgeon’s knee replacement patients reached the function target. CMS rates this 1 of 5 stars. The CMS 5-star benchmark is 52%. Higher is better.
Surgery October 1, 2022–September 30, 2023; assessment 9–15 months later.
Measures attaining a function target, not percentage improved.
Missing timely assessments count as not meeting the target.
CMS stars are measure-specific performance categories, not an overall doctor rating.
Current office locations do not identify where historical care took place.
Numerical differences do not establish statistically significant superiority.
Eligible patients irrespective of payer under MIPS CQM completeness rules; payer-specific results absent.
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: overall.
Overall Percentage for patients (aged 5-50 years) with well-controlled asthma, without elevated risk of exacerbation; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultsWellCtrl.
Asthma well-controlled (submit the most recent specified asthma control tool result) for patients 18 to 50 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Diabetes: HbA1c poor control (>9%), 2024. A lower percentage is better. A higher percentage means more patients had a poor result.
Eligible patients with diabetes whose most recent HbA1c exceeded 9%; absent assessment also counts as poor control.
Intermediate outcome; no case-mix adjustment.
Age: 18–75; stratum: overall.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Doctor result · PY 2024 Clinician Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Controlling high blood pressure, 2024. Higher is better.
Eligible essential-hypertension patients with most recent blood pressure below 140/90 mmHg in the period.
Missing BP counts as not controlled.
Intermediate outcome; no case-mix adjustment.
Age: 18–85; stratum: overall.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Functional Status After Primary Total Knee Replacement · Doctor result · PY 2023 Clinician Public Reporting: MIPS Measures and Attestations
0% of this surgeon’s knee replacement patients reached the function target in CMS reporting year 2023. Higher is better.
The 2023 reporting year covers primary total knee replacements performed October 1, 2021–September 30, 2022.
The assessment occurs 9–15 months after surgery.
The published target requires an Oxford Knee Score of at least 37 or a KOOS, JR.
score of at least 71.
A missing timely assessment counts as target not met.
The measure records target attainment, not improvement from baseline.
Historical cohorts remain separate.
These results do not establish year-to-year improvement or statistical superiority.
The population includes eligible adults who received primary total knee replacement under the published 2023 MIPS measure definition. This row does not publish payer-specific results or the location of historical surgery.
Missing values stay missing. A grey value means the publisher reported no figure, often because there were too few cases. It does not mean the result is bad.
The reviewed data do not publish this result.
Loading…
Loading…
Loading…
Loading…
Drug companies must report to CMS Open Payments what they pay doctors. Medicare publishes each doctor's Part D prescriptions. This section shows the payments and prescriptions side by side. The overlap does not show that a payment changed a prescription.
Loading…
data.cms.gov · released 10 Sep 2026
data.cms.gov · released 12 Nov 2026
Centers for Medicare & Medicaid Services; public aggregate provider data; no endorsement.
This data consists of CMS public aggregate clinician outcome data with source attribution. The 2023 reporting year and surgery cohort remain separate from the archive date. The data includes no questionnaire text, patient-level records, overall doctor rating or government endorsement.
Missing evidence is not zero and does not mean poor care. Source list · Coverage and freshness